No­var­tis eyes a new mar­ket with its buy­out of a small dig­i­tal ther­a­peu­tics play­er

No­var­tis has scooped up a dig­i­tal ther­a­peu­tics play­er work­ing on a new treat­ment for lazy eye.

The com­pa­ny is Phoenix-based Am­bly­otech, which has been pur­su­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER